MichelleL.MellionMD

Neurology • Providence, RI

Neurophysiology

Assistant Professor, Neurology, Brown University Program in Medicine

Join to view full profile

Dr. Mellion is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mellion's full profile

Already have an account?

Office
2 Dudley St
Ste 555
Providence, RI 02905
Phone+1 401-444-3032

Fax+1 401-444-3205

Education & Training

Brown UniversityFellowship, Clinical Neurophysiology, 2005 - 2006
Brown UniversityResidency, Neurology, 2002 - 2005
Brown UniversityInternship, Internal Medicine, 2001 - 2002
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2001

Certifications & Licensure

RI State Medical License 2005 - 2026
MA State Medical License 2006 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Clinical Neurophysiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013

Publications & Presentations

PubMed

11 citations
Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.
Michelle L Mellion, Per Widholm, Markus Karlsson, André Ahlgren, Rabi Tawil
Neurology. 2022-08-30
17 citations
Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement
Michelle Mellion, Lucienne Ronco, Cécile Berends, Lisa Pagan, Sander Brooks
British Journal of Clinical Pharmacology. 2021-05-14
396 citations
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-bli...
James F. Howard, Kimiaki Utsugisawa, Michael Benatar, Hiroyuki Murai, Richard J. Barohn
The Lancet. Neurology. 2017-12-01

Press Mentions

PepGen Appoints Michelle Mellion, M.D., as Senior Vice President, Head of Clinical DevelopmentApril 5th, 2022
Phase 1 Results Support Losmapimod as FSHD TreatmentMarch 26th, 2020
Fulcrum Therapeutics Announces Phase 1 Clinical Trial ResultsOctober 4th, 2019